Obadia Y - Search Results

1

Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group.

Carrieri MP, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y. Carrieri MP, et al. Among authors: obadia y. Drug Alcohol Depend. 2000 Jul 1;60(1):51-4. doi: 10.1016/s0376-8716(99)00136-2. Drug Alcohol Depend. 2000. PMID: 10821989

2

Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.

Rey D, Carrieri MP, Spire B, Loubière S, Dellamonica P, Gallais H, Cassuto GP, Gastaut JA, Obadia Y; MANIF 2000 Study Group. Rey D, et al. Among authors: obadia y. J Urban Health. 2004 Mar;81(1):48-57. doi: 10.1093/jurban/jth087. J Urban Health. 2004. PMID: 15047783 Free PMC article.

3

Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group.

Reynaud-Maurupt C, Carrieri MP, Gastaud JA, Pradier C, Obadia Y, Moatti JP. Reynaud-Maurupt C, et al. Among authors: obadia y. AIDS Care. 2000 Aug;12(4):461-70. doi: 10.1080/09540120050123864. AIDS Care. 2000. PMID: 11091779

4

Injecting misuse of buprenorphine among French drug users.

Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP. Obadia Y, et al. Addiction. 2001 Feb;96(2):267-72. doi: 10.1046/j.1360-0443.2001.96226710.x. Addiction. 2001. PMID: 11182872

5

Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users.

Carrieri MP, Rey D, Loundou A, Lepeu G, Sobel A, Obadia Y; MANIF-2000 Study Group. Carrieri MP, et al. Among authors: obadia y. Drug Alcohol Depend. 2003 Oct 24;72(1):13-21. doi: 10.1016/s0376-8716(03)00189-3. Drug Alcohol Depend. 2003. PMID: 14563539

6

Nonadherence among HIV-infected injecting drug users: the impact of social instability.

Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, Moatti JP, Obadia Y, Spire B; MANIF 2000 Study Group. Bouhnik AD, et al. Among authors: obadia y. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S149-53. doi: 10.1097/00126334-200212153-00013. J Acquir Immune Defic Syndr. 2002. PMID: 12562040

7

Drug injection cessation among HIV-infected injecting drug users.

Bouhnik AD, Carrieri MP, Rey D, Spire B, Gastaut JA, Gallais H, Obadia Y; MANIF 2000 Study Group. Bouhnik AD, et al. Among authors: obadia y. Addict Behav. 2004 Aug;29(6):1189-97. doi: 10.1016/j.addbeh.2004.01.006. Addict Behav. 2004. PMID: 15236822

8

Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.

Vincent E, Bouhnik AD, Carrieri MP, Rey D, Dujardin P, Granier F, Fuzibet JG, Obadia Y, Moatti JP, Spire B; MANIF-2000 Study Group. Vincent E, et al. Among authors: obadia y. AIDS. 2004 Jun 18;18(9):1321-5. doi: 10.1097/00002030-200406180-00011. AIDS. 2004. PMID: 15362665

9

Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).

Peretti-Watel P, Spire B, Lert F, Obadia Y; VESPA Group. Peretti-Watel P, et al. Among authors: obadia y. Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S71-9. doi: 10.1016/s0376-8716(06)80012-8. Drug Alcohol Depend. 2006. PMID: 16769450

10

Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B; VESPA Study Group. Préau M, et al. Among authors: obadia y. AIDS. 2007 Jan;21 Suppl 1:S19-27. doi: 10.1097/01.aids.0000255081.24105.d7. AIDS. 2007. PMID: 17159583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters